U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
79.99
-0.58 (-0.72%)
At close: Mar 10, 2026, 4:00 PM EDT
79.99
0.00 (0.00%)
After-hours: Mar 10, 2026, 4:20 PM EDT
U.S. Physical Therapy Stock Forecast
Stock Price Forecast
The 5 analysts that cover U.S. Physical Therapy stock have a consensus rating of "Strong Buy" and an average price target of $105.6, which forecasts a 32.02% increase in the stock price over the next year. The lowest target is $100 and the highest is $113.
Price Target: $105.6 (+32.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for U.S. Physical Therapy stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $102 | Strong Buy | Initiates | $102 | +27.52% | Mar 10, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $103 | Buy | Maintains | $103 | +28.77% | Feb 20, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $103 | Buy | Maintains | $103 | +28.77% | Jan 5, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $110 → $100 | Buy | Maintains | $110 → $100 | +25.02% | Nov 24, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $103 | Buy | Maintains | $103 | +28.77% | Oct 24, 2025 |
Financial Forecast
Revenue This Year
846.34M
from 773.34M
Increased by 9.44%
Revenue Next Year
900.76M
from 846.34M
Increased by 6.43%
EPS This Year
3.11
from 1.42
Increased by 118.49%
EPS Next Year
3.51
from 3.11
Increased by 13.14%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 887.7M | 964.0M | |
| Avg | 846.3M | 900.8M | |
| Low | 798.2M | 853.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.8% | 13.9% | |
| Avg | 9.4% | 6.4% | |
| Low | 3.2% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.51 | 4.02 | |
| Avg | 3.11 | 3.51 | |
| Low | 2.74 | 3.18 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 146.7% | 29.5% | |
| Avg | 118.5% | 13.1% | |
| Low | 93.0% | 2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.